Sökning: onr:"swepub:oai:lup.lub.lu.se:0c554e6e-df79-452c-86c3-29086e5da412" >
Exploring IL-17 in ...
Exploring IL-17 in spondyloarthritis for development of novel treatments and biomarkers
-
- Groen, Solveig Skovlund (författare)
- University of Copenhagen,Nordic Bioscience AS
-
- Sinkeviciute, Dovile (författare)
- Lund University,Lunds universitet,Reumatologi och molekylär skelettbiologi,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Molekylär skelettbiologi,Forskargrupper vid Lunds universitet,Rheumatology,Section III,Department of Clinical Sciences, Lund,Faculty of Medicine,Molecular Skeletal Biology,Lund University Research Groups,Nordic Bioscience AS
-
- Bay-Jensen, Anne Christine (författare)
- Nordic Bioscience AS
-
visa fler...
-
- Thudium, Christian S. (författare)
- Nordic Bioscience AS
-
- Karsdal, Morten A. (författare)
- Nordic Bioscience AS
-
- Thomsen, Simon Francis (författare)
- Bispebjerg Hospital,University of Copenhagen
-
- Schett, Georg (författare)
- Friedrich-Alexander University Erlangen-Nürnberg
-
- Nielsen, Signe Holm (författare)
- Technical University of Denmark,Nordic Bioscience AS
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2021
- 2021
- Engelska.
-
Ingår i: Autoimmunity Reviews. - : Elsevier BV. - 1568-9972. ; 20:3
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://doi.org/10.1...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Spondyloarthritis (SpA) is an umbrella term describing a family of chronic inflammatory rheumatic diseases. These diseases are characterised by inflammation of the axial skeleton, peripheral joints, and entheseal insertion sites throughout the body which can lead to structural joint damage including formation of axial syndesmophytes and peripheral osteophytes. Genetic evidence, preclinical and clinical studies indicate a clear role of interleukin (IL)- 23 and IL-17 as mediators in SpA pathogenesis. Targeting the IL-23/−17 pathways seems an efficient strategy for treatment of SpA patients, and despite the remaining challenges the pathway holds great promise for further advances and improved therapeutic opportunities. Much research is focusing on serological markers and imaging strategies to correctly diagnose patients in the early stages of SpA. Biomarkers may facilitate personalised medicine tailored to each patient's specific disease to optimise treatment efficacy and to monitor therapeutic response. This narrative review focuses on the IL-17 pathway in SpA-related diseases with emphasis on its role in pathogenesis, current approved IL-17 inhibitors, and the need for biomarkers reflecting core disease pathways for early diagnosis and measurement of disease activity, prognosis, and response to therapy.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Reumatologi och inflammation (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Rheumatology and Autoimmunity (hsv//eng)
Nyckelord
- Biomarker
- IL-17
- pathogenesis
- Spondyloarthritis
- treatment
Publikations- och innehållstyp
- for (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas